Literature DB >> 15281905

Topoisomerase I-DNA complex stability induced by camptothecins and its role in drug activity.

Randy M Wadkins1, David Bearss, Govindarajan Manikumar, Mansukhlal C Wani, Monroe E Wall, Daniel D Von Hoff.   

Abstract

The mechanism of cytotoxicity of the camptothecin family of antitumor drugs is thought to be the consequence of a collision between moving replication forks and camptothecin-stabilized cleavable DNA-topoisomerase I complexes. One property of camptothecin analogs relevant to their potent antitumor activity is the slow reversal of the cleavable complexes formed with these drugs. The persistence of cleavable complexes with time may be an essential property for increasing the likelihood of a collision between the replication fork and a cleavable complex, giving rise to lethal DNA lesions. In this paper, we examined a number of camptothecin analogs forming cleavable complexes with distinctly different stabilities. Absolute reaction rate analysis was carried out for each derivative. Our results indicate that the stability of the cleavable complex is dominated by the activation entropy (DeltaS++) of the reversal process. We measured the relative lipophilicity of the CPT analogs by reverse-phase HPLC, but the DeltaS++ of complex reversal is not directly related to the lipophilicity of the CPT analog being used. We suggest that solvent ordering around the 7- through 10-position of the CPT ring may be responsible for reversal rate's dependence on DeltaS++. We demonstrate that the cleavable complex stability conferred by each camptothecin analog is directly correlated with the induction of apoptosis and cytotoxicity to tumor cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15281905     DOI: 10.2174/1568011043352894

Source DB:  PubMed          Journal:  Curr Med Chem Anticancer Agents        ISSN: 1568-0118


  5 in total

1.  Calculated Log D Is Inversely Correlated With Select Camptothecin Clearance and Efficacy in Colon Cancer Xenografts.

Authors:  Charvi Nanavati; Donald E Mager
Journal:  J Pharm Sci       Date:  2016-04       Impact factor: 3.534

2.  Exploring the cellular activity of camptothecin-triple-helix-forming oligonucleotide conjugates.

Authors:  Paola B Arimondo; Craig J Thomas; Kahina Oussedik; Brigitte Baldeyrou; Christine Mahieu; Ludovic Halby; Dominique Guianvarc'h; Amélie Lansiaux; Sidney M Hecht; Christian Bailly; Carine Giovannangeli
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

3.  Dexamethasone inhibits camptothecin-induced apoptosis in C6-glioma via activation of Stat5/Bcl-xL pathway.

Authors:  Yi-Hua Qian; Qingli Xiao; Hong Chen; Jan Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-07

4.  B-ring-aryl substituted luotonin A analogues with a new binding mode to the topoisomerase 1-DNA complex show enhanced cytotoxic activity.

Authors:  Víctor González-Ruiz; Irene Pascua; Tamara Fernández-Marcelo; Pascual Ribelles; Giulia Bianchini; Vellaisamy Sridharan; Pilar Iniesta; M Teresa Ramos; Ana I Olives; M Antonia Martín; J Carlos Menéndez
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

5.  Human non‑small cell lung cancer cells can be sensitized to camptothecin by modulating autophagy.

Authors:  Yi-Han Chiu; Shih-Hsien Hsu; Hsiao-Wei Hsu; Kuo-Chin Huang; Wangta Liu; Chang-Yi Wu; Wei-Pang Huang; Jeff Yi-Fu Chen; Bing-Hung Chen; Chien-Chih Chiu
Journal:  Int J Oncol       Date:  2018-08-14       Impact factor: 5.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.